Leo Linbeck, III

Mr. Linbeck has been the Chairman for more than a decade, and recently served as the Executive Chairman until September 2019. He is CEO of Aquinas Companies, a private, diversified holding company with annual revenues in excess of $300 million. He is Founder and Chairman of Fannin Innovation Studio, Houston’s most active life science technology development company. Under his leadership, Fannin has launched more than 15 companies and raised dilutive and non-dilutive funding of more than $125 million. He is one of the inventors of the Brevitest diagnostic system, and holds a number of patents. He serves on the board of Procyrion, a clinical-stage medical device company and is interim President of Raptamer Discovery Group, a next-generation aptamer development company. He has been on the faculty of Stanford Graduate School of Business since 2005 and is active in a number of political and philanthropic organizations.